A massive @mathonco.bsky.social congratulations to Dr. Weh @gosiaweh.bsky.social on successfully defending her PhD. Also a shoutout to both her advisors @cancerevo.org and Andriy Marusyk @moffittnews.bsky.social
Our innovative SonoCloud technology has been used to treat the first glioblastoma patient in Florida!
A huge thank you to @moffittnews.bsky.social for their dedication and expertise in making this possible.
Want to learn more ?
www.moffitt.org/endeavor/arc...
#Glioblastoma #ClinicalTrials
Moffitt is heading to Chicago for #AACR25! We are excited to share our latest science and connect with fellow oncology professionals. More than 50 Moffitt experts are presenting.
For a full list of Moffitt presentations, visit moffitt.org/AACR25.
Looking forward to their insights. See you in Chicago for #AACR25!
We're looking forward to their insights from #AACR25. See you in Chicago!
A team of researchers at Moffitt Cancer Center has found a new drug combination that could help overcome resistance in a tough-to-treat form of lung cancer. #AACR25
Stop by and meet the Moffitt team at the #AACR25 Career Fair! Learn about career opportunities and how we’re advancing cancer research and care. #MoffittAACR25
@theaacr.bsky.social
A milestone day at SPEROS FL! 🏗 These milestones symbolize hope for today’s patients and future generations.
After a 4,600-mile journey from Belgium, our cyclotron has arrived at SPEROS FL.
This robust accelerator will power Tampa Bay’s first proton therapy system, making Moffitt the region’s first health system to offer this advanced cancer treatment. #SperosFL
Join us on Saturday, Nov. 22, as we walk, run, and come together to support lifesaving cancer research. We’re thrilled to celebrate 20 incredible years of Miles for Moffitt!
Registration is officially open, and all distances start as low as $30* for a limited time. Register now: bit.ly/4dSn8tK
Check out the new article published in the Journal of Cardiothoracic and Vascular Anesthesia by @moffittnews.bsky.social #Anesthesiology team members on their experience with Percutaneous Hepatic Perfusion Procedures!
authors.elsevier.com/c/1kvXD3lSIP...
More than 700 biotech innovators, investors, and researchers gathered for the 18th annual Business of Biotech at Moffitt, exploring the future of patient-driven, personalized cancer care. Together, we're shaping the future of oncology. #MoffittBoB
Patients will be treated with new combination therapy recently approved for pancreatic cancer.
“The best thing I could do is get on a clinical trial, and not just for me, but for everyone who walks these halls at Moffitt and halls like this everywhere.”
Kicking off our first panel discussion with top cell therapy experts in science, business & innovation!
Panelists are exploring the future of cell therapy, from breakthrough science to new models of management and manufacturing & how collaboration can bring these treatments to patients. #MoffittBoB
In the #MoffittBoB closing keynote, Seema Verma, EVP and General Manager of Oracle Health and Life Sciences shares how integrating clinical research with care delivery and leveraging #AI is reshaping healthcare to improve patient outcomes.
💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer
Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI
Our next keynote speaker, Levi Garraway, Head of Global Product Development and Chief Medical Officer at Roche, shares his inspiring career journey from academia to the biotech industry. #MoffittBoB
We're thrilled to welcome our first keynote speaker, Craig Maxwell, SVP, Head of Oncology R&D at AstraZeneca. He shared valuable insights into the future of personalized cancer care, highlighting the importance of academia and industry collaborations. #MoffittBoB
Today for the 18th annual Business of Biotech, over 700 biotech executives, entrepreneurs, venture capitalists, angel investors and researchers from across the U.S. are at Moffitt for a unique opportunity to collaborate. #MoffittBoB
Excited to be joined by biotech executives, entrepreneurs, investors and researchers today at #MoffittBoB to discuss the latest advances in cancer care. A big thank you to Florida Secretary of Commerce Alex Kelly for kicking off the event at our leadership breakfast.
@moffittnews.bsky.social
Moffitt is thrilled to be in Chicago in two weeks for #AACR25!
SON-1010 Plus Atezolizumab Is Safe, Displays Preliminary Efficacy in Platinum-Resistant Ovarian Cancer
@moffittnews.bsky.social #OvarianCancer
www.onclive.com/view/son-101...
An esophageal cancer diagnosis in 2021 wasn’t enough to keep Ronald Guiliano off the pickleball court.
The 18th annual Business of Biotech conference is this week! Join 400+ biotech leaders, including executives, entrepreneurs, investors and researchers, as we explore the latest breakthroughs in cancer care.
Register now: web.cvent.com/event/4c6437...
#MoffittBoB
We have a special I-Beam that will form part of our new @moffittnews.bsky.social Discovery and Innovation Center at Speros. I just added my signature today - it will be interesting to see it in place soon. Hopefully we'll see many new important therapeutic discoveries there!
Deeply honored to be featured by @moffittnews.bsky.social in this "Where Are They Now?" article that highlights how my Moffitt experience prepared me for my current position at HJF and USUHS www.moffitt.org/education/re...
New on the blog: Dr. Lary Robinson of Moffitt Cancer Center shares insights on a clinical trial evaluating the CIZ1B blood test for early lung cancer detection. Read the first post in our Clinical Thought Leadership series. 🔗 www.cizzlebio.com/clinical-tho...
@moffittnews.bsky.social
